| Line Item | 2025-06-27 | Y/Y |
|---|---|---|
| Revenue | $9.10B | +38.9% |
| Cost of Revenue | $5.90B | +17.6% |
| R&D Expense | $724.0M | +10.7% |
| SG&A Expense | $561.0M | +22.0% |
| Operating Income | $1.89B | +318.1% |
| Pre-tax Income | $1.51B | +240.0% |
| Income Tax | $44.0M | -60.0% |
| Net Income | $1.47B | +338.5% |
| EPS (Basic) | $6.93 |
| Line Item | 2025-06-27 | Y/Y |
|---|---|---|
| Cash & Equivalents | $891.0M | -34.4% |
| Accounts Receivable | $959.0M | +123.5% |
| Inventory | $1.44B | +16.2% |
| Current Assets | $3.65B | +9.6% |
| Total Assets | $8.02B | +3.7% |
| Current Liabilities | $2.65B | -14.6% |
| Long-term Debt | $5.00B | -3.8% |
| Line Item | 2025-06-27 | Y/Y |
|---|---|---|
| Operating Cash Flow | $1.08B | +18.0% |
| Capital Expenditures | $265.0M | +4.3% |
| Investing Cash Flow | -$276.0M | -319.0% |
| Financing Cash Flow | -$1.27B | -169.3% |
| Free Cash Flow | $818.0M | +23.2% |
| +333.1% |
| EPS (Diluted) | $6.77 | +328.5% |
| Total Liabilities |
| $8.48B |
| -8.2% |
| Stockholders' Equity | -$453.0M | +69.6% |